Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Labcorp logoLabcorp LH

The company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.

8-KRegulation FD DisclosureFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.

  2. The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

  3. The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. It said a replay will be available approximately 2 hours after the conclusion of the live event, through February 1, 2025.

  4. The company said in its press release that more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q4 2023 and Full-Year Earnings Release Schedule

The company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.

Source · Based on the filing body and exhibits

Conference Call and Webcast

The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Source · Based on the filing body and exhibits

Participation Method and Replay Availability

The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. It said a replay will be available approximately 2 hours after the conclusion of the live event, through February 1, 2025.

Source · Based on the filing body and exhibits

Company Overview Scale Figures

The company said in its press release that more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.